Jason Cheek
Psychiatric/Mental Health · Battle Ground, WANPI 1427754191
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 155 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $34.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$796
- Johnson & Johnson$739
- Axsome Therapeutics, Inc.$679
- Teva Pharmaceuticals USA, Inc.$488
- Otsuka America Pharmaceutical, Inc.$444
- Supernus Pharmaceuticals, Inc.$392
- plus $2K from 11 others
What the payments were for
- Food & beverage$5,360100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $796 |
| Johnson & Johnson | 16 | $739 |
| Axsome Therapeutics, Inc. | 16 | $679 |
| Teva Pharmaceuticals USA, Inc. | 14 | $488 |
| Otsuka America Pharmaceutical, Inc. | 4 | $444 |
| Supernus Pharmaceuticals, Inc. | 10 | $392 |
| Corium, LLC | 13 | $363 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $326 |
| Bausch Health US, LLC | 15 | $277 |
| Lundbeck LLC | 12 | $258 |
| Alkermes, Inc. | 6 | $197 |
| Vanda Pharmaceuticals Inc. | 5 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $87 |
| Neurocrine Biosciences, Inc. | 3 | $58 |
| Collegium Pharmaceutical, Inc. | 1 | $26 |
| Noven Therapeutics, LLC | 1 | $21 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,360 in reported general payments places this provider in the 95th percentile of 931 psychiatric/mental health providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 11 | $173 |
| Lamotrigine | 15 | $158 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Battle Ground
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Dawn MasonSpokane$25K
- Jennifer WilsonYakima$23K
- Kojo SarfoEllensburg$20K
- Brendan RoeVancouver$18K
- Jenna VoKent$18K
- Kelly BlissSeattle$18K
- Agnes MarambaKent$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.